The vaccine, known as CoronaVac, is still in phase 3 clinical trials in Brazil and has not been registered for wider use in Brazil, Anvisa said.
Brazil health auth. OKs import of 6 mln doses of Chinese COVID-19 vaccine
By REUTERS
04/20/2024 04:59 AM
By REUTERS
04/20/2024 02:43 AM
By REUTERS
04/20/2024 01:36 AM
By REUTERS
04/19/2024 11:25 PM
By REUTERS
04/19/2024 08:27 PM
By REUTERS
04/19/2024 07:13 PM
By URI SELA
04/19/2024 06:26 PM
By REUTERS
04/19/2024 05:59 PM
By REUTERS
04/19/2024 03:23 PM
By REUTERS
04/19/2024 03:20 PM